DE602004023098D1 - Neues lactobacillus, den lebenden körper aktivierende lactobacilluspräparation sowie präventivmittel oder therapeutikum gegen eine infektion des lebenden körpers - Google Patents

Neues lactobacillus, den lebenden körper aktivierende lactobacilluspräparation sowie präventivmittel oder therapeutikum gegen eine infektion des lebenden körpers

Info

Publication number
DE602004023098D1
DE602004023098D1 DE602004023098T DE602004023098T DE602004023098D1 DE 602004023098 D1 DE602004023098 D1 DE 602004023098D1 DE 602004023098 T DE602004023098 T DE 602004023098T DE 602004023098 T DE602004023098 T DE 602004023098T DE 602004023098 D1 DE602004023098 D1 DE 602004023098D1
Authority
DE
Germany
Prior art keywords
lactobacillus
living body
species
preventive
therapeutic agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004023098T
Other languages
English (en)
Inventor
Tadayo Hata
Hitoshi Toshimori
Toshiyuki Maruoka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BHPH Co Ltd
Original Assignee
BHPH Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BHPH Co Ltd filed Critical BHPH Co Ltd
Publication of DE602004023098D1 publication Critical patent/DE602004023098D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • C12R2001/245Lactobacillus casei
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE602004023098T 2003-07-30 2004-07-27 Neues lactobacillus, den lebenden körper aktivierende lactobacilluspräparation sowie präventivmittel oder therapeutikum gegen eine infektion des lebenden körpers Expired - Lifetime DE602004023098D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003203802 2003-07-30
PCT/JP2004/010639 WO2005012503A1 (ja) 2003-07-30 2004-07-27 新規乳酸菌並びに生体賦活型乳酸菌製剤及び生体に対する感染症の予防剤と治療剤

Publications (1)

Publication Number Publication Date
DE602004023098D1 true DE602004023098D1 (de) 2009-10-22

Family

ID=34113630

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004023098T Expired - Lifetime DE602004023098D1 (de) 2003-07-30 2004-07-27 Neues lactobacillus, den lebenden körper aktivierende lactobacilluspräparation sowie präventivmittel oder therapeutikum gegen eine infektion des lebenden körpers

Country Status (19)

Country Link
US (1) US7863033B2 (de)
EP (1) EP1661982B1 (de)
JP (1) JP4661593B2 (de)
KR (1) KR100763257B1 (de)
CN (1) CN1842588B (de)
AT (1) ATE442154T1 (de)
AU (1) AU2004261832B2 (de)
BR (1) BRPI0413008B8 (de)
CA (1) CA2534013C (de)
DE (1) DE602004023098D1 (de)
ES (1) ES2332411T3 (de)
HK (1) HK1095605A1 (de)
HR (1) HRP20090583T1 (de)
IN (1) IN2006MU00214A (de)
MX (1) MXPA06001167A (de)
RU (1) RU2340669C2 (de)
UA (1) UA88271C2 (de)
WO (1) WO2005012503A1 (de)
ZA (1) ZA200600866B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101525633B (zh) * 2009-04-13 2012-01-04 天津科技大学 一种乳杆菌产抗植物致病真菌发酵液的制备方法
JP5612870B2 (ja) * 2010-02-26 2014-10-22 コンビ株式会社 褥瘡改善作用を有する組成物
RU2465322C2 (ru) * 2010-12-09 2012-10-27 Российская Федерация, от имени которой выступает Министерство образования и науки Российской Федерации (Минобрнауки России) ШТАММ БАКТЕРИЙ Lactobacillus casei/paracasei - ВГНКИ 10.02.62 ДЕП, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПРИГОТОВЛЕНИЯ ПРОБИОТИЧЕСКОЙ ДОБАВКИ
EP2578088A1 (de) * 2011-10-06 2013-04-10 Nestec S.A. Essbares Netz mit Mikroorganismen
EP3013150A4 (de) 2013-06-27 2017-03-08 Starbucks Corporation D/b/a Starbucks Coffee Company Verfahren zur biokonservierung von getränken und anderen nahrungsmitteln
CN104293691B (zh) * 2014-06-13 2017-09-19 杨雄 一株能降低抗药性的嗜酸乳杆菌及其制备的生物制剂
JP5703513B1 (ja) * 2014-11-05 2015-04-22 沖縄ハム総合食品株式会社 新規乳酸菌株及びその乳酸菌株による発酵組成物及び醗酵エキス
CN105362297B (zh) * 2015-09-22 2019-03-08 福建贝迪药业有限公司 一种用于防控雏禽肠道病原的复合微生态制剂及其制备方法
US10363279B2 (en) * 2016-02-20 2019-07-30 Nubiome, Inc. Treatment and prophylaxis for neurological conditions and diseases
BE1024189B1 (nl) 2016-10-28 2017-12-05 Yun NV Spuitbus met bacteriële species
JP7228200B2 (ja) 2017-03-23 2023-02-24 ユニバーシタット アントウェルペン 新規のプロバイオティックなラクトバチルス・カゼイ株及びその使用
WO2019216438A1 (ja) * 2018-05-11 2019-11-14 株式会社セルテクノロジー 間葉系細胞の培養上清を含む歯周病治療剤
CN109943507B (zh) * 2019-03-26 2021-08-17 中国兽医药品监察所 一种兽用a型产气荚膜梭菌类毒素的制备方法及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4716791B1 (de) * 1968-10-20 1972-05-17
JPS52102419A (en) * 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
GB1585863A (en) 1977-08-24 1981-03-11 Seiken Kai Foundational Juridi Pharmaceutical lactobacillus preparations
FR2400901A1 (fr) 1977-08-26 1979-03-23 Seiken Kai Foundational Juridi Preparations pharmaceutiques de lactobacillus, utiles notamment comme anti-infectieux
DE2738652C3 (de) 1977-08-26 1981-02-19 Seiken Kai Foundation Juridical Person, Tondabayashi, Osaka (Japan) Lactobacillus-Präparat und seine Verwendung bei der Bekämpfung bakterieller Infektionen und Entzündungen
US4579740A (en) * 1983-07-11 1986-04-01 Microlife Technics, Inc. Fermentation method using a selected lactobacillus
JP3958456B2 (ja) * 1998-12-25 2007-08-15 高梨乳業株式会社 血清脂質改善効果を有する機能性飲食品
JP2000217566A (ja) * 1999-01-25 2000-08-08 Bhph Co Ltd ラクトバチラスクリアランスを培養するための培養基および該菌種の保存方法
JP4193269B2 (ja) * 1999-03-04 2008-12-10 ビーエイチピーエイチ カンパニーリミテッド 新規な生体浄化活性型乳酸菌製剤
EP1038951A1 (de) 1999-03-23 2000-09-27 Societe Des Produits Nestle S.A. Synthetisches Mittel für die Züchtung von Lactobacillus und/oder die Bifidobacterien
ES2226228T5 (es) 1999-04-30 2009-01-16 Societe Des Produits Nestle S.A. Crecimiento mejorado de las bacterias del acido lactico en la leche.
JP4193330B2 (ja) * 2000-05-24 2008-12-10 ビーエイチピーエイチ カンパニーリミテッド 新規な感染症対応型乳酸菌および該乳酸菌を主成分とした乳酸菌製剤
KR100419132B1 (ko) * 2000-12-29 2004-02-18 조성근 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:h7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이csk 01
JP4528472B2 (ja) * 2001-11-29 2010-08-18 ビオフェルミン製薬株式会社 歯周病の予防または治療剤

Also Published As

Publication number Publication date
WO2005012503A1 (ja) 2005-02-10
CN1842588B (zh) 2010-09-29
EP1661982A4 (de) 2007-03-14
JPWO2005012503A1 (ja) 2007-09-27
KR100763257B1 (ko) 2007-10-04
ZA200600866B (en) 2007-04-25
HK1095605A1 (en) 2007-05-11
MXPA06001167A (es) 2006-10-30
UA88271C2 (uk) 2009-10-12
BRPI0413008B8 (pt) 2021-05-25
RU2340669C2 (ru) 2008-12-10
IN2006MU00214A (de) 2007-06-15
HRP20090583T1 (hr) 2009-12-31
JP4661593B2 (ja) 2011-03-30
BRPI0413008B1 (pt) 2017-06-20
ES2332411T3 (es) 2010-02-04
EP1661982A1 (de) 2006-05-31
RU2006106279A (ru) 2006-08-27
CA2534013C (en) 2010-11-02
BRPI0413008A (pt) 2006-10-17
US7863033B2 (en) 2011-01-04
EP1661982B1 (de) 2009-09-09
ATE442154T1 (de) 2009-09-15
AU2004261832B2 (en) 2007-10-04
AU2004261832A1 (en) 2005-02-10
US20080293126A1 (en) 2008-11-27
CN1842588A (zh) 2006-10-04
CA2534013A1 (en) 2005-02-10
KR20060037412A (ko) 2006-05-03

Similar Documents

Publication Publication Date Title
HK1095605A1 (en) Novel lactobacillus, living body activating lactobacillus preparation and preventive or therapeutic agent against living body infection
ES2331993T3 (es) Bacillus subtilis para uso contra patogenos animales y humanos.
AU2002350530A1 (en) Composition comprising a lactobacillus pentosus strain and uses thereof
ATE439138T1 (de) Probiotika zur primären prävention atopischer erkrankungen
NO20053462L (no) Ernaeringsformulering surgjort med melkesyre
Slyvka et al. Strains of lactic acid bacteria isolated from traditional Carpathian cheeses
EP3464609A1 (de) Verfahren zur herstellung mikrobieller probiotischer biofilme und verwendungen davon
DE60123986D1 (de) Verwendung eines mittels zur verbesserung des knochenmetabolismus
BRPI0511314A (pt) bactérias lácticas e seu uso na prevenção de diarréia
MX2022014451A (es) Bacterias de acido lactico bioprotectoras con baja posacidificacion.
ATE544471T1 (de) Zusammensetzung mit iscom-teilchen und lebenden mikroorganismen
CN108410763B (zh) 长双歧杆菌tc01及其应用和应用其的产品
del Pozo et al. Granulicatella adiacens breast implant-associated infection
ATE541468T1 (de) Mikrobielle futterergänzungsmittel und verwendungen davon in verfahren zur verringerung und/oder verhinderung von azidose in polygastrischen pflanzenfressern
Goudarzi et al. evaluation of antimicrobial activity of probiotic lactobacillus strains against growth and urease activity of proteus spp.
Prol‐García et al. Phaeobacter grown in biofilters: A new strategy for the control of Vibrionaceae in aquaculture
Sharma et al. Bacteriological analysis of bile culture from a tertiary care hospital
Amdekar et al. In vitro antibacterial activity of Lactobacillus casei against enteropathogens
Al-Mathkhury et al. Probiotic effect of lactobacilli on mice incisional wound infections
Al-Jumaily et al. Optimal conditions for acidocin production from Lactobacillus acidophilus isolate
Suresh et al. Antibacterial activity of Lactobacillus (LB) strains isolated from goat milk against ESBL producing E. coli causing wound infections
Mishra et al. Isolation and characterization of probiotic microorganism from fermented dairy products
Aforijiku et al. Antagonistic effect of developed probiotic yoghurt against some selected food-borne pathogens during cold storage
Yazici et al. Phenotypic characterization and antibiotic susceptibilities of ewingella americana and kluyvera intermedia isolated from soaked hides and skins
Fahad et al. Effect of Lactobacillus acidophilus on Escherichia coli causing urinary tract infections in vitro and in vivo

Legal Events

Date Code Title Description
8364 No opposition during term of opposition